114 related articles for article (PubMed ID: 12419362)
1. Chemical modification of reveromycin A and its biological activities.
Shimizu T; Usui T; Machida K; Furuya K; Osada H; Nakata T
Bioorg Med Chem Lett; 2002 Dec; 12(23):3363-6. PubMed ID: 12419362
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological activities of reveromycin A and spirofungin A derivatives.
Shimizu T; Usui T; Fujikura M; Kawatani M; Satoh T; Machida K; Kanoh N; Woo JT; Osada H; Sodeoka M
Bioorg Med Chem Lett; 2008 Jul; 18(13):3756-60. PubMed ID: 18519164
[TBL] [Abstract][Full Text] [Related]
3. Structure-function analyses of cytochrome P450revI involved in reveromycin A biosynthesis and evaluation of the biological activity of its substrate, reveromycin T.
Takahashi S; Nagano S; Nogawa T; Kanoh N; Uramoto M; Kawatani M; Shimizu T; Miyazawa T; Shiro Y; Osada H
J Biol Chem; 2014 Nov; 289(47):32446-58. PubMed ID: 25258320
[TBL] [Abstract][Full Text] [Related]
4. Reveromycin A, a new antibiotic which inhibits the mitogenic activity of epidermal growth factor.
Osada H; Koshino H; Isono K; Takahashi H; Kawanishi G
J Antibiot (Tokyo); 1991 Feb; 44(2):259-61. PubMed ID: 2010365
[No Abstract] [Full Text] [Related]
5. Reveromycins, new inhibitors of eukaryotic cell growth. II. Biological activities.
Takahashi H; Osada H; Koshino H; Sasaki M; Onose R; Nakakoshi M; Yoshihama M; Isono K
J Antibiot (Tokyo); 1992 Sep; 45(9):1414-9. PubMed ID: 1429226
[TBL] [Abstract][Full Text] [Related]
6. Chemical and biological studies of reveromycin A.
Osada H
J Antibiot (Tokyo); 2016 Oct; 69(10):723-730. PubMed ID: 27270304
[TBL] [Abstract][Full Text] [Related]
7. Identification of Saccharomyces cerevisiae isoleucyl-tRNA synthetase as a target of the G1-specific inhibitor Reveromycin A.
Miyamoto Y; Machida K; Mizunuma M; Emoto Y; Sato N; Miyahara K; Hirata D; Usui T; Takahashi H; Osada H; Miyakawa T
J Biol Chem; 2002 Aug; 277(32):28810-4. PubMed ID: 12050165
[TBL] [Abstract][Full Text] [Related]
8. Reveromycins, new inhibitors of eukaryotic cell growth. I. Producing organism, fermentation, isolation and physico-chemical properties.
Takahashi H; Osada H; Koshino H; Kudo T; Amano S; Shimizu S; Yoshihama M; Isono K
J Antibiot (Tokyo); 1992 Sep; 45(9):1409-13. PubMed ID: 1429225
[TBL] [Abstract][Full Text] [Related]
9. Enantioselective synthesis of the [6,6] spiroketal core of reveromycin A.
Drouet KE; Ling T; Tran HV; Theodorakis EA
Org Lett; 2000 Jan; 2(2):207-10. PubMed ID: 10814283
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of spiro[indole-thiazolidine]spiro[indole-pyrans] as antimicrobial agents.
Sakhuja R; Panda SS; Khanna L; Khurana S; Jain SC
Bioorg Med Chem Lett; 2011 Sep; 21(18):5465-9. PubMed ID: 21782421
[TBL] [Abstract][Full Text] [Related]
11. Spirofungin A: stereoselective synthesis and inhibition of isoleucyl-tRNA synthetase.
Marjanovic J; Kozmin SA
Angew Chem Int Ed Engl; 2007; 46(46):8854-7. PubMed ID: 17929337
[No Abstract] [Full Text] [Related]
12. Total synthesis of reveromycin A.
Shimizu T; Masuda T; Hiramoto K; Nakata T
Org Lett; 2000 Jul; 2(14):2153-6. PubMed ID: 10891254
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationship for FR901464: a versatile method for the conversion and preparation of biologically active biotinylated probes.
Motoyoshi H; Horigome M; Ishigami K; Yoshida T; Horinouchi S; Yoshida M; Watanabe H; Kitahara T
Biosci Biotechnol Biochem; 2004 Oct; 68(10):2178-82. PubMed ID: 15502365
[TBL] [Abstract][Full Text] [Related]
14. Convergent approach to complex spirocyclic pyrans: practical synthesis of the oxa-pinnaic acid core.
Ferrari FD; Pasqua AE; Ledgard AJ; Marquez R
Org Biomol Chem; 2013 Jun; 11(21):3469-76. PubMed ID: 23589153
[TBL] [Abstract][Full Text] [Related]
15. Reveromycin A, an agent for osteoporosis, inhibits bone resorption by inducing apoptosis specifically in osteoclasts.
Woo JT; Kawatani M; Kato M; Shinki T; Yonezawa T; Kanoh N; Nakagawa H; Takami M; Lee KH; Stern PH; Nagai K; Osada H
Proc Natl Acad Sci U S A; 2006 Mar; 103(12):4729-34. PubMed ID: 16537392
[TBL] [Abstract][Full Text] [Related]
16. The spiroketals containing a benzyloxymethyl moiety at C8 position showed the most potent apoptosis-inducing activity.
Mitsuhashi S; Shima H; Kawamura T; Kikuchi K; Oikawa M; Ichihara A; Oikawa H
Bioorg Med Chem Lett; 1999 Jul; 9(14):2007-12. PubMed ID: 10450971
[TBL] [Abstract][Full Text] [Related]
17. Stereoselective total synthesis of reveromycin B and C19-epi-reveromycin B.
Drouet KE; Theodorakis EA
Chemistry; 2000 Jun; 6(11):1987-2001. PubMed ID: 10894398
[TBL] [Abstract][Full Text] [Related]
18. Total synthesis of the epidermal growth factor inhibitor (-)-reveromycin B.
Cuzzupe AN; Hutton CA; Lilly MJ; Mann RK; McRae KJ; Zammit SC; Rizzacasa MA
J Org Chem; 2001 Apr; 66(7):2382-93. PubMed ID: 11281779
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of novel antitumor spirotetrahydrothiopyran-oxindole derivatives as potent p53-MDM2 inhibitors.
Ji C; Wang S; Chen S; He S; Jiang Y; Miao Z; Li J; Sheng C
Bioorg Med Chem; 2017 Oct; 25(20):5268-5277. PubMed ID: 28797774
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic Spliceostatins from Burkholderia sp. and Their Semisynthetic Analogues.
He H; Ratnayake AS; Janso JE; He M; Yang HY; Loganzo F; Shor B; O'Donnell CJ; Koehn FE
J Nat Prod; 2014 Aug; 77(8):1864-70. PubMed ID: 25098528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
